SKI Market

A+| A| A-|

Indian Indices

Sensex

75,315.04 77.05
( 0.10%)

Global Indices

Nasdaq

49,708.56 161.38
(0.33%)

Dow Jones

7,424.10 -5.40
(-0.07%)

Hang Seng

60,874.73 -534.56
(-0.87%)

Nikkei 225

10,297.25 101.88
(1.00%)

Forex

USD-INR

95.71 0.07
(0.07%)

EUR-INR

111.93 -0.13
(-0.12%)

GBP-INR

129.01 -0.31
(-0.24%)

JPY-INR

0.61 0.00
(-0.09%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

78871

INE0L4V01013

17.34

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VILINBIO

329.33

75.34

EPS(TTM)

Face Value()

Div & Yield %

0.15

Back

a b infrabuild ltd

Regent Enterprises standalone net profit rises 366.67% in the December 2025 quarter

Feb 13,2026

Net profit of Regent Enterprises rose 366.67% to Rs 1.82 crore in the quarter ended December 2025 as against Rs 0.39 crore during the previous quarter ended December 2024. Sales rose 21.38% to Rs 272.33 crore in the quarter ended December 2025 as against Rs 224.37 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	272.33	224.37	21
OPM %	0.71	0.10	-
PBDT	1.94	0.23	743
PBT	1.80	0.10	1700
NP	1.82	0.39	367

75,315.04 77.05 ( 0.10%)

49,708.56 161.38 (0.33%)

7,424.10 -5.40 (-0.07%)

60,874.73 -534.56 (-0.87%)

10,297.25 101.88 (1.00%)

95.71 0.07 (0.07%)

111.93 -0.13 (-0.12%)

129.01 -0.31 (-0.24%)

0.61 0.00 (-0.09%)